pI: 6.0278 |
Length (AA): 343 |
MW (Da): 36608 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
36 | 225 | 2e9x (B) | 2 | 175 | 28.00 | 0 | 1 | 0.885836 | -0.58 |
117 | 150 | 2kh2 (B) | 89 | 122 | 53.00 | 0.27 | 0.04 | 0.461325 | 1.62 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | metacyclic. | Fernandes MC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | amastigotes. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128484)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G12530 | DNA replication complex GINS protein PSF2 |
Brugia malayi | Bm1_28470 | Probable DNA replication complex GINS protein PSF2, putative |
Candida albicans | CaO19.57 | similar to C terminus of S. cerevisiae PSF2 (YJL072C) component of the GINS complex involved in DNA replication initiation |
Candida albicans | CaO19.7718 | similar to C terminus of S. cerevisiae PSF2 (YJL072C) component of the GINS complex involved in DNA replication initiation |
Caenorhabditis elegans | CELE_F31C3.5 | Protein F31C3.5 |
Cryptosporidium parvum | cgd1_3410 | DNA replication complex GINS protein PSF2, putative |
Dictyostelium discoideum | DDB_G0293564 | GINS complex subunit 2 |
Drosophila melanogaster | Dmel_CG18013 | CG18013 gene product from transcript CG18013-RC |
Echinococcus granulosus | EgrG_000795300 | dna replication complex gins protein psf2 |
Entamoeba histolytica | EHI_069340 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000795300 | dna replication complex gins protein psf2 |
Homo sapiens | 51659 | GINS complex subunit 2 (Psf2 homolog) |
Leishmania braziliensis | LbrM.35.4440 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_364400.1 | GINS complex protein, putative |
Leishmania infantum | LinJ.36.4400 | hypothetical protein, conserved |
Leishmania major | LmjF.36.4190 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.4190 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_12803 | hypothetical protein |
Loa Loa (eye worm) | LOAG_14962 | hypothetical protein |
Mus musculus | 272551 | GINS complex subunit 2 (Psf2 homolog) |
Oryza sativa | 4327215 | Os01g0248600 |
Saccharomyces cerevisiae | YJL072C | Psf2p |
Schistosoma japonicum | Sjp_0001940 | ko:K10733 DNA replication complex GINS protein PSF2, putative |
Schistosoma mansoni | Smp_100380 | hypothetical protein |
Schmidtea mediterranea | mk4.004320.01 | |
Trypanosoma brucei gambiense | Tbg972.11.11730 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.10460 | dna replication complex gins protein psf2 |
Trypanosoma congolense | TcIL3000.11.11020 | GINS complex protein, putative |
Trypanosoma cruzi | TcCLB.510283.150 | dna replication complex gins protein psf2 |
Trypanosoma cruzi | TcCLB.503823.110 | dna replication complex gins protein psf2 |
Trichomonas vaginalis | TVAG_174630 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.2230 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.2230 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.2230 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.2230 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F31C3.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F31C3.5 | Caenorhabditis elegans | larval arrest | wormbase |
YJL072C | Saccharomyces cerevisiae | inviable | yeastgenome |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.